Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.

Heijerman HGM, McKone EF, Downey DG, Van Braeckel E, Rowe SM, Tullis E, Mall MA, Welter JJ, Ramsey BW, McKee CM, Marigowda G, Moskowitz SM, Waltz D, Sosnay PR, Simard C, Ahluwalia N, Xuan F, Zhang Y, Taylor-Cousar JL, McCoy KS; VX17-445-103 Trial Group.

Lancet. 2019 Nov 23;394(10212):1940-1948. doi: 10.1016/S0140-6736(19)32597-8. Epub 2019 Oct 31.

PMID:
31679946
2.

Weighing in on asthma: Insights on BMI, magnesium, and hospitalizations from the Ohio Pediatric Asthma Repository.

Schuler CL, Biagini Myers JM, Kercsmar CM, Pilipenko VV, Kroner JW, Simmons JM, Austin SR, Gunkelman SM, Ross KR, McCoy KS, Kalra M, Ruddy JR, Martin LJ, Khurana Hershey GK.

J Asthma. 2019 Aug 14:1-8. doi: 10.1080/02770903.2019.1652639. [Epub ahead of print]

PMID:
31411907
3.

Ohio Pediatric Asthma Repository: Opportunities to Revise Care Practices to Decrease Time to Physiologic Readiness for Discharge.

Simmons JM, Biagini Myers JM, Martin LJ, Kercsmar CM, Schuler CL, Pilipenko VV, Kroner JW, He H, Austin SR, Nguyen HT, Ross KR, McCoy KS, Alter SJ, Gunkelman SM, Vauthy PA, Khurana Hershey GK.

Hosp Pediatr. 2018 Jun;8(6):305-313. doi: 10.1542/hpeds.2017-0085. Epub 2018 May 15.

4.

Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis. A Randomized, Controlled, Multicenter Clinical Trial.

Sagel SD, Khan U, Jain R, Graff G, Daines CL, Dunitz JM, Borowitz D, Orenstein DM, Abdulhamid I, Noe J, Clancy JP, Slovis B, Rock MJ, McCoy KS, Strausbaugh S, Livingston FR, Papas KA, Shaffer ML.

Am J Respir Crit Care Med. 2018 Sep 1;198(5):639-647. doi: 10.1164/rccm.201801-0105OC.

5.

Estimating nearshore coral reef-associated fisheries production from the main Hawaiian Islands.

McCoy KS, Williams ID, Friedlander AM, Ma H, Teneva L, Kittinger JN.

PLoS One. 2018 Apr 16;13(4):e0195840. doi: 10.1371/journal.pone.0195840. eCollection 2018.

6.

Adjunctive Pharmacotherapies in Children With Asthma Exacerbations Requiring Continuous Albuterol Therapy: Findings From The Ohio Pediatric Asthma Repository.

Shein SL, Farhan O, Morris N, Mahmood N, Alter SJ, Biagini Myers JM, Gunkelman SM, Kercsmar CM, Khurana Hershey GK, Martin LJ, McCoy KS, Ruddy JR, Ross KR.

Hosp Pediatr. 2018 Jan 5. pii: hpeds.2017-0088. doi: 10.1542/hpeds.2017-0088. [Epub ahead of print]

7.

The expression of Mirc1/Mir17-92 cluster in sputum samples correlates with pulmonary exacerbations in cystic fibrosis patients.

Krause K, Kopp BT, Tazi MF, Caution K, Hamilton K, Badr A, Shrestha C, Tumin D, Hayes D Jr, Robledo-Avila F, Hall-Stoodley L, Klamer BG, Zhang X, Partida-Sanchez S, Parinandi NL, Kirkby SE, Dakhlallah D, McCoy KS, Cormet-Boyaka E, Amer AO.

J Cyst Fibros. 2018 Jul;17(4):454-461. doi: 10.1016/j.jcf.2017.11.005. Epub 2017 Dec 11.

8.

Erratum to: Racial differences in pet ownership in families of children with asthma.

Sheikh SI, Pitts J, Ryan-Wenger NA, McCoy KS, Hayes D Jr.

World J Pediatr. 2017 Dec;13(6):625. doi: 10.1007/s12519-017-0042-5.

PMID:
28940144
9.

Role of CFTR mutation analysis in the diagnostic algorithm for cystic fibrosis.

Ratkiewicz M, Pastore M, McCoy KS, Thompson R, Hayes D Jr, Sheikh SI.

World J Pediatr. 2017 Apr;13(2):129-135. doi: 10.1007/s12519-017-0015-8. Epub 2017 Feb 15.

PMID:
28194692
10.

Improved quality-of-life of caregivers of children with asthma through guideline-based management.

Sheikh SI, Pitts J, Ryan-Wenger NA, Kotha K, McCoy KS, Stukus DR.

J Asthma. 2017 Sep;54(7):768-776. doi: 10.1080/02770903.2016.1258077. Epub 2016 Nov 10.

PMID:
27831828
11.

Novel Computed Tomography Scoring System for Sinus Disease in Adults With Cystic Fibrosis.

Sheikh SI, Handly B, Ryan-Wenger NA, Hayes D Jr, Kirkby SE, McCoy KS, Lind M.

Ann Otol Rhinol Laryngol. 2016 Oct;125(10):838-43. doi: 10.1177/0003489416656645. Epub 2016 Jun 29.

PMID:
27357973
12.

Racial differences in pet ownership in families of children with asthma.

Sheikh SI, Pitts J, Ryan-Wenger NA, McCoy KS, Hayes D.

World J Pediatr. 2016 Aug;12(3):343-346. doi: 10.1007/s12519-016-0027-9. Epub 2016 Jun 29. Erratum in: World J Pediatr. 2017 Dec;13(6):625.

PMID:
27351569
13.

Environmental exposures and family history of asthma.

Sheikh SI, Pitts J, Ryan-Wenger NA, McCoy KS, Hayes D Jr.

J Asthma. 2016 Jun;53(5):465-70. doi: 10.3109/02770903.2015.1108440. Epub 2016 Jan 20.

PMID:
26786935
14.

Pulmonary Artery Pressure and Benefit of Lung Transplantation in Adult Cystic Fibrosis Patients.

Hayes D Jr, Tumin D, Daniels CJ, McCoy KS, Mansour HM, Tobias JD, Kirkby SE.

Ann Thorac Surg. 2016 Mar;101(3):1104-9. doi: 10.1016/j.athoracsur.2015.09.086. Epub 2015 Dec 11.

PMID:
26687141
15.

Improving pediatric asthma care: A partnership between pediatric primary care clinics and a free-standing Children's Hospital.

Sheikh SI, Chrysler M, Ryan-Wenger NA, Hayes D Jr, McCoy KS.

J Asthma. 2016 Aug;53(6):622-8. doi: 10.3109/02770903.2015.1126845. Epub 2016 Apr 15.

PMID:
26666448
16.

Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation.

Hayes D Jr, Patel AV, Black SM, McCoy KS, Kirkby S, Tobias JD, Mansour HM, Whitson BA.

J Thorac Cardiovasc Surg. 2015 Sep;150(3):707-13.e2. doi: 10.1016/j.jtcvs.2015.06.041. Epub 2015 Jun 26.

17.

Screening high-risk children for asthma through a community intervention.

Sheikh SI, Pitts J, Ryan-Wenger NA, McCoy KS, Hayes D Jr.

J Asthma. 2015 Oct;52(8):801-5. doi: 10.3109/02770903.2015.1008142. Epub 2015 Jul 23.

PMID:
26203824
18.

Eucapnic Voluntary Hyperventilation to Detect Exercise-Induced Bronchoconstriction in Cystic Fibrosis.

Kirkby SE, Hayes D Jr, Parsons JP, Wisely CE, Kopp B, McCoy KS, Mastronarde JG.

Lung. 2015 Oct;193(5):733-8. doi: 10.1007/s00408-015-9745-3. Epub 2015 Jun 3.

PMID:
26036953
19.

Behavioral and nutritional treatment for preschool-aged children with cystic fibrosis: a randomized clinical trial.

Powers SW, Stark LJ, Chamberlin LA, Filigno SS, Sullivan SM, Lemanek KL, Butcher JL, Driscoll KA, Daines CL, Brody AS, Schindler T, Konstan MW, McCoy KS, Nasr SZ, Castile RG, Acton JD, Wooldridge JL, Ksenich RA, Szczesniak RD, Rausch JR, Stallings VA, Zemel BS, Clancy JP.

JAMA Pediatr. 2015 May;169(5):e150636. doi: 10.1001/jamapediatrics.2015.0636. Epub 2015 May 4.

PMID:
25938655
20.

Changes in Pulmonary Function and Controlled Ventilation-High Resolution CT of Chest After Antibiotic Therapy in Infants and Young Children with Cystic Fibrosis.

Sheikh SI, Long FR, Flucke R, Ryan-Wenger NA, Hayes D Jr, McCoy KS.

Lung. 2015 Jun;193(3):421-8. doi: 10.1007/s00408-015-9706-x. Epub 2015 Mar 12.

PMID:
25762451
21.

Improvement of hepatic steatosis in cystic fibrosis with ivacaftor therapy.

Hayes D Jr, Warren PS, McCoy KS, Sheikh SI.

J Pediatr Gastroenterol Nutr. 2015 May;60(5):578-9. doi: 10.1097/MPG.0000000000000765.

PMID:
25688481
22.

Heterogeneity in asthma care in a statewide collaborative: the Ohio Pediatric Asthma Repository.

Biagini Myers JM, Simmons JM, Kercsmar CM, Martin LJ, Pilipenko VV, Austin SR, Lindsey MA, Amalfitano KM, Guilbert TW, McCoy KS, Forbis SG, McBride JT, Ross KR, Vauthy PA, Khurana Hershey GK.

Pediatrics. 2015 Feb;135(2):271-9. doi: 10.1542/peds.2014-2230. Epub 2015 Jan 19.

23.

Galectin-9 ameliorates respiratory syncytial virus-induced pulmonary immunopathology through regulating the balance between Th17 and regulatory T cells.

Lu X, McCoy KS, Xu J, Hu W, Chen H, Jiang K, Han F, Chen P, Wang Y.

Virus Res. 2015 Jan 2;195:162-71. doi: 10.1016/j.virusres.2014.10.011. Epub 2014 Oct 16.

PMID:
25451068
24.

High-risk age window for mortality in children with cystic fibrosis after lung transplantation.

Hayes D Jr, McCoy KS, Whitson BA, Mansour HM, Tobias JD.

Pediatr Transplant. 2015 Mar;19(2):206-10. doi: 10.1111/petr.12401. Epub 2014 Nov 28.

PMID:
25430504
25.

Pulmonary hypertension in cystic fibrosis with advanced lung disease.

Hayes D Jr, Tobias JD, Mansour HM, Kirkby S, McCoy KS, Daniels CJ, Whitson BA.

Am J Respir Crit Care Med. 2014 Oct 15;190(8):898-905. doi: 10.1164/rccm.201407-1382OC.

PMID:
25222938
26.

Improvement in bronchiectasis on CT imaging in a pediatric patient with cystic fibrosis on ivacaftor therapy.

Hayes D Jr, Long FR, McCoy KS, Sheikh SI.

Respiration. 2014;88(4):345. doi: 10.1159/000365999. Epub 2014 Aug 21. No abstract available.

27.

Resolution of cystic fibrosis-related diabetes with ivacaftor therapy.

Hayes D Jr, McCoy KS, Sheikh SI.

Am J Respir Crit Care Med. 2014 Sep 1;190(5):590-1. doi: 10.1164/rccm.201405-0882LE. No abstract available.

PMID:
25171312
28.

Ivacaftor improves appearance of sinus disease on computerised tomography in cystic fibrosis patients with G551D mutation.

Sheikh SI, Long FR, McCoy KS, Johnson T, Ryan-Wenger NA, Hayes D Jr.

Clin Otolaryngol. 2015 Feb;40(1):16-21. doi: 10.1111/coa.12310.

PMID:
25145599
29.

Improvement of sinus disease in cystic fibrosis with ivacaftor therapy.

Hayes D Jr, McCoy KS, Sheikh SI.

Am J Respir Crit Care Med. 2014 Aug 15;190(4):468. doi: 10.1164/rccm.201403-0595IM. No abstract available.

PMID:
25127305
30.

CT imaging of pediatric patients with cystic fibrosis on ivacaftor therapy.

Hayes D Jr, Long FR, McCoy KS, Sheikh SI.

Lung. 2014 Oct;192(5):823-4. doi: 10.1007/s00408-014-9629-y. Epub 2014 Aug 7. No abstract available.

PMID:
25099273
31.

Computed tomography correlates with improvement with ivacaftor in cystic fibrosis patients with G551D mutation.

Sheikh SI, Long FR, McCoy KS, Johnson T, Ryan-Wenger NA, Hayes D Jr.

J Cyst Fibros. 2015 Jan;14(1):84-9. doi: 10.1016/j.jcf.2014.06.011. Epub 2014 Jul 19.

32.

Stigma and optimism in adolescents and young adults with cystic fibrosis.

Oliver KN, Free ML, Bok C, McCoy KS, Lemanek KL, Emery CF.

J Cyst Fibros. 2014 Dec;13(6):737-44. doi: 10.1016/j.jcf.2014.04.005. Epub 2014 May 1.

33.

Lobectomy in patients with cystic fibrosis.

Sheikh SI, McCoy KS, Ryan-Wenger NA, Patel A, Kirkby S.

Can Respir J. 2014 Jul-Aug;21(4):e63-6. Epub 2014 Feb 12.

34.

Impact of pulmonary hypertension on survival in patients with cystic fibrosis undergoing lung transplantation: an analysis of the UNOS registry.

Hayes D Jr, Higgins RS, Kirkby S, McCoy KS, Wehr AM, Lehman AM, Whitson BA.

J Cyst Fibros. 2014 Jul;13(4):416-23. doi: 10.1016/j.jcf.2013.12.004. Epub 2013 Dec 30.

35.

Dexamethasone reduces IL-17 and Tim-3 expression in BALF of asthmatic mice.

Lu XX, McCoy KS, Hu WK, Xu JL, Wang HQ, Chen P, Chen HB.

J Huazhong Univ Sci Technolog Med Sci. 2013 Aug;33(4):479-484. doi: 10.1007/s11596-013-1145-4. Epub 2013 Aug 1.

PMID:
23904364
36.

Right heart catheterization measuring central hemodynamics in cystic fibrosis during exercise.

Hayes D Jr, Daniels CJ, Mansour HM, Kopp BT, Yates AR, McCoy KS, Patel AV, Kirkby S.

Respir Med. 2013 Sep;107(9):1365-9. doi: 10.1016/j.rmed.2013.02.020. Epub 2013 Jul 2.

37.

Demographics, clinical course, and outcomes of children with status asthmaticus treated in a pediatric intensive care unit: 8-year review.

Sheikh S, Khan N, Ryan-Wenger NA, McCoy KS.

J Asthma. 2013 May;50(4):364-9. doi: 10.3109/02770903.2012.757781. Epub 2013 Feb 5.

PMID:
23379585
38.

Small interfering RNA targeting T-cell Ig mucin-3 decreases allergic airway inflammation and hyperresponsiveness.

Lu XX, McCoy KS, Xu JL, Hu WK, Chen HB.

Inflammation. 2013 Jun;36(3):582-91. doi: 10.1007/s10753-012-9580-0.

PMID:
23232962
39.

Targeting bacterial integration host factor to disrupt biofilms associated with cystic fibrosis.

Gustave JE, Jurcisek JA, McCoy KS, Goodman SD, Bakaletz LO.

J Cyst Fibros. 2013 Jul;12(4):384-9. doi: 10.1016/j.jcf.2012.10.011. Epub 2012 Nov 17.

40.

Outcomes of surgical management of severe GERD in patients with cystic fibrosis.

Sheikh SI, Ryan-Wenger NA, McCoy KS.

Pediatr Pulmonol. 2013 Jun;48(6):556-62. doi: 10.1002/ppul.22630. Epub 2012 Sep 4.

PMID:
22949398
41.

Health literacy and willingness to use online health information by teens with asthma and diabetes.

Chisolm DJ, Hardin DS, McCoy KS, Johnson LD, McAlearney AS, Gardner W.

Telemed J E Health. 2011 Nov;17(9):676-82. doi: 10.1089/tmj.2011.0037. Epub 2011 Sep 23.

42.

Inpatient healthcare trends among adult cystic fibrosis patients in the U.S.

Kopp BT, Wang W, Chisolm DJ, Kelleher KJ, McCoy KS.

Pediatr Pulmonol. 2012 Mar;47(3):245-51. doi: 10.1002/ppul.21535. Epub 2011 Sep 7.

43.

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.

Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, Ashlock MA, Ballmann M, Boyle MP, Bronsveld I, Campbell PW, De Boeck K, Donaldson SH, Dorkin HL, Dunitz JM, Durie PR, Jain M, Leonard A, McCoy KS, Moss RB, Pilewski JM, Rosenbluth DB, Rubenstein RC, Schechter MS, Botfield M, OrdoƱez CL, Spencer-Green GT, Vernillet L, Wisseh S, Yen K, Konstan MW.

Thorax. 2012 Jan;67(1):12-8. doi: 10.1136/thoraxjnl-2011-200393. Epub 2011 Aug 8.

44.

Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).

Oermann CM, McCoy KS, Retsch-Bogart GZ, Gibson RL, McKevitt M, Montgomery AB.

J Antimicrob Chemother. 2011 Oct;66(10):2398-404. doi: 10.1093/jac/dkr303. Epub 2011 Jul 22.

PMID:
21784781
45.

An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis.

Oermann CM, Retsch-Bogart GZ, Quittner AL, Gibson RL, McCoy KS, Montgomery AB, Cooper PJ.

Pediatr Pulmonol. 2010 Nov;45(11):1121-34. doi: 10.1002/ppul.21301.

46.

Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis.

Retsch-Bogart GZ, Quittner AL, Gibson RL, Oermann CM, McCoy KS, Montgomery AB, Cooper PJ.

Chest. 2009 May;135(5):1223-1232. doi: 10.1378/chest.08-1421.

47.

Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.

McCoy KS, Quittner AL, Oermann CM, Gibson RL, Retsch-Bogart GZ, Montgomery AB.

Am J Respir Crit Care Med. 2008 Nov 1;178(9):921-8. doi: 10.1164/rccm.200712-1804OC. Epub 2008 Jul 24.

48.

Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome.

McCoy KS.

N Engl J Med. 2007 Nov 29;357(22):2310-1. doi: 10.1056/NEJMc071717. No abstract available.

PMID:
18046039
49.

The role of computerized order sets in pediatric inpatient asthma treatment.

Chisolm DJ, McAlearney AS, Veneris S, Fisher D, Holtzlander M, McCoy KS.

Pediatr Allergy Immunol. 2006 May;17(3):199-206.

PMID:
16672007
50.

Gas trapping in normal infants and in infants with cystic fibrosis.

Castile RG, Iram D, McCoy KS.

Pediatr Pulmonol. 2004 May;37(5):461-9.

PMID:
15095331

Supplemental Content

Loading ...
Support Center